Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome

NCT00134810 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

381

Enrollment

INDUSTRY

Sponsor class

Conditions

Myofascial Pain Syndromes

Interventions

BIOLOGICAL: Botulinum toxin type A

Sponsor

Ipsen